News

Published on 10 May 2024 on Zacks via Yahoo Finance

Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)


Article preview image

Investors are always looking for stocks that are poised to beat at earnings season and ANI Pharmaceuticals, Inc. ANIP may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because ANI Pharmaceuticals is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for ANIP in this report.In fact, the Most Accurate Estimate for the current quarter is currently at $1.07 per share for ANIP, compared to a broader Zacks Consensus Estimate of 98 cents per share. This suggests that analysts have very recently bumped up their estimates for ANIP, giving the stock a Zacks Earnings ESP of +9.74% heading into earnings season.

ANI Pharmaceuticals, Inc. Price and EPS Surprise

ANI Pharmaceuticals, Inc. Price and EPS SurpriseANI Pharmaceuticals, Inc. Price and EPS Surprise

NASDAQ.ANIP price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
ANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Selle...

Insider Monkey · via Yahoo Finance 19 Aug 2024

ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) just released its quarterly report and things are looking...

Simply Wall St. via Yahoo Finance 16 May 2024

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)

On May 14, 2024, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), execut...

GuruFocus.com via Yahoo Finance 16 May 2024

Earnings call: ANI Pharmaceuticals announced a 29% increase in total revenues By Investing.com

ANI Pharmaceuticals (NASDAQ:ANIP), Inc. (ANI) has announced a significant 29% year-over-year...

Investing.com 10 May 2024

Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)

Investors are always looking for stocks that are poised to beat at earnings season and ANI Pharma...

Zacks via Yahoo Finance 10 May 2024

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What...

Most readers would already be aware that ANI Pharmaceuticals' (NASDAQ:ANIP) stock increased signi...

Simply Wall St. via Yahoo Finance 10 May 2024

Will Petrobras (PBR) Report Q1 Earnings Beat on Output Gains?

Petroleo Brasileiro S.A., or Petrobras PBR is set to release first-quarter 2024 results on May 13...

Zacks via Yahoo Finance 9 May 2024

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

We expect investors to focus on the initial sales numbers of CRISPR Therapeutics AG’s CRSP newly ...

Zacks via Yahoo Finance 7 May 2024

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

ANI Pharmaceuticals ANIP is slated to report first-quarter 2024 results on May 10, before the ope...

Zacks via Yahoo Finance 7 May 2024

Ani Pharmaceuticals executive sells over $1.3 million in stock By Investing.com

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant stock transaction by one of it...

Investing.com 4 May 2024